149 related articles for article (PubMed ID: 16449284)
1. The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysis.
den Elzen WP; van Manen JG; Boeschoten EW; Krediet RT; Dekker FW
Nephrol Dial Transplant; 2006 Jun; 21(6):1588-95. PubMed ID: 16449284
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein is a strong predictor of mortality in hemodialysis patients.
Racki S; Zaputović L; Mavrić Z; Vujicić B; Dvornik S
Ren Fail; 2006; 28(5):427-33. PubMed ID: 16825093
[TBL] [Abstract][Full Text] [Related]
3. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
[TBL] [Abstract][Full Text] [Related]
4. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients.
Boulier A; Jaussent I; Terrier N; Maurice F; Rivory JP; Chalabi L; Boularan AM; Delcourt C; Dupuy AM; Canaud B; Cristol JP
Nephrol Dial Transplant; 2004 Sep; 19(9):2313-8. PubMed ID: 15252159
[TBL] [Abstract][Full Text] [Related]
5. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
[TBL] [Abstract][Full Text] [Related]
6. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
[TBL] [Abstract][Full Text] [Related]
7. Effect of an increase in C-reactive protein level during a hemodialysis session on mortality.
Korevaar JC; van Manen JG; Dekker FW; de Waart DR; Boeschoten EW; Krediet RT;
J Am Soc Nephrol; 2004 Nov; 15(11):2916-22. PubMed ID: 15504945
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
9. Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients--no additional power for mortality prediction with high-sensitivity CRP.
Grootendorst DC; de Jager DJ; Brandenburg VM; Boeschoten EW; Krediet RT; Dekker FW;
Nephrol Dial Transplant; 2007 Nov; 22(11):3277-84. PubMed ID: 17623721
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein and electrocardiographic ST-segment depression additively predict mortality: the Strong Heart Study.
Okin PM; Roman MJ; Best LG; Lee ET; Galloway JM; Howard BV; Devereux RB
J Am Coll Cardiol; 2005 Jun; 45(11):1787-93. PubMed ID: 15936607
[TBL] [Abstract][Full Text] [Related]
11. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients.
de Mutsert R; Grootendorst DC; Axelsson J; Boeschoten EW; Krediet RT; Dekker FW;
Nephrol Dial Transplant; 2008 Sep; 23(9):2957-64. PubMed ID: 18400817
[TBL] [Abstract][Full Text] [Related]
12. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
[TBL] [Abstract][Full Text] [Related]
13. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort.
Goodson NJ; Symmons DP; Scott DG; Bunn D; Lunt M; Silman AJ
Arthritis Rheum; 2005 Aug; 52(8):2293-9. PubMed ID: 16052597
[TBL] [Abstract][Full Text] [Related]
14. Association between a self-rated health question and mortality in young and old dialysis patients: a cohort study.
Thong MS; Kaptein AA; Benyamini Y; Krediet RT; Boeschoten EW; Dekker FW;
Am J Kidney Dis; 2008 Jul; 52(1):111-7. PubMed ID: 18511166
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
16. White blood cell count predicts all-cause, cardiovascular disease-cause and infection-cause one-year mortality of maintenance hemodialysis patients.
Hsu CW; Lin JL; Lin-Tan DT; Yen TH; Chen KH
Ther Apher Dial; 2010 Dec; 14(6):552-9. PubMed ID: 21118362
[TBL] [Abstract][Full Text] [Related]
17. Increased circulating inflammatory proteins predict a worse prognosis with valvular calcification in end-stage renal disease: a prospective cohort study.
Wang AY; Lam CW; Wang M; Chan IH; Yu CM; Lui SF; Sanderson JE
Am J Nephrol; 2008; 28(4):647-53. PubMed ID: 18292652
[TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.
Genovesi S; Vincenti A; Rossi E; Pogliani D; Acquistapace I; Stella A; Valsecchi MG
Am J Kidney Dis; 2008 Feb; 51(2):255-62. PubMed ID: 18215703
[TBL] [Abstract][Full Text] [Related]
19. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients.
Panichi V; Maggiore U; Taccola D; Migliori M; Rizza GM; Consani C; Bertini A; Sposini S; Perez-Garcia R; Rindi P; Palla R; Tetta C
Nephrol Dial Transplant; 2004 May; 19(5):1154-60. PubMed ID: 14993508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
